ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach.

Biotechnology

Health Data

Health Diagnostics

Life Sciences

Therapeutics

ProPhase Labs

Ted Karkus

Joseph Brennan

Igor Ban

Jason Karkus

Sergio M.

Monica Brady

Jed Latkin

Leadership Team

Analytical and Operational Functions

Teams at ProPhase Labs

Leadership Team

Analytical and Operational Functions